Sign up to save your podcasts
Or
Share The worldwide weight-loss revolution
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The worldwide weight-loss revolution
GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay.
In the second episode of our Business Daily series on the global weight-loss economy, Sam Fenwick examines how different countries are funding — or rationing — access to these high-priced injections.
In England, the state's National Health System says the drugs offer good value for money, and yet rollout is being phased in slowly because of cost and capacity pressures. In the United Arab Emirates, most patients rely on private insurance or pay out of their own pockets. And in India, where obesity is rising fast, affordability remains a major barrier, although lower-cost generics may soon change that.
If these medicines can prevent diabetes, heart attacks and strokes, they might save health systems money in the long run. But right now, governments, insurers and patients are grappling with the same question: Can we afford the weight-loss revolution?
Produced and presented by Sam Fenwick
If you’d like to get in touch with the team, our email address is [email protected]
Business Daily is the home of in-depth audio journalism devoted to the world of money and work. From small start-up stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.
Each episode is a 17-minute deep dive into a single topic, featuring expert analysis and the people at the heart of the story.
Recent episodes explore the growth in AI, the cost of living, why bond markets are so powerful, China's property bubble, and Gen Z's experience of the current job market.
We also feature in-depth interviews with company founders and some of the world's most prominent CEOs. These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, CEO of Canva Melanie Perkins, and the CEO of Starbucks, Brian Niccol.
(Photo: A man gets his waist measured. Credit: Getty Images)
View all episodes
By BBC World Service
4.4
488488 ratings
GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay.
In the second episode of our Business Daily series on the global weight-loss economy, Sam Fenwick examines how different countries are funding — or rationing — access to these high-priced injections.
In England, the state's National Health System says the drugs offer good value for money, and yet rollout is being phased in slowly because of cost and capacity pressures. In the United Arab Emirates, most patients rely on private insurance or pay out of their own pockets. And in India, where obesity is rising fast, affordability remains a major barrier, although lower-cost generics may soon change that.
If these medicines can prevent diabetes, heart attacks and strokes, they might save health systems money in the long run. But right now, governments, insurers and patients are grappling with the same question: Can we afford the weight-loss revolution?
Produced and presented by Sam Fenwick
If you’d like to get in touch with the team, our email address is [email protected]
Business Daily is the home of in-depth audio journalism devoted to the world of money and work. From small start-up stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.
Each episode is a 17-minute deep dive into a single topic, featuring expert analysis and the people at the heart of the story.
Recent episodes explore the growth in AI, the cost of living, why bond markets are so powerful, China's property bubble, and Gen Z's experience of the current job market.
We also feature in-depth interviews with company founders and some of the world's most prominent CEOs. These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, CEO of Canva Melanie Perkins, and the CEO of Starbucks, Brian Niccol.
(Photo: A man gets his waist measured. Credit: Getty Images)
More shows like Business Daily
View all
Global News Podcast
7,825 Listeners
Economist Podcasts
4,190 Listeners
Newshour
1,064 Listeners
World Business Report
298 Listeners
Bloomberg Businessweek
437 Listeners
In Our Time
5,531 Listeners
The Documentary Podcast
1,800 Listeners
Friday Night Comedy from BBC Radio 4
2,097 Listeners
The Interview
356 Listeners
English News - NHK WORLD RADIO JAPAN
438 Listeners
Big Boss Interview
51 Listeners
The Life Scientific
228 Listeners
Learning English from the News
252 Listeners
Evil Genius with Russell Kane
357 Listeners
Have You Heard George's Podcast?
236 Listeners
FT News Briefing
653 Listeners
Behind the Money
234 Listeners
Elis James and John Robins
329 Listeners
You're Dead to Me
3,210 Listeners
Sport's Strangest Crimes
77 Listeners
Uncanny
676 Listeners
Lady Killers with Lucy Worsley
574 Listeners
Believe in Magic
625 Listeners
The Global Story
385 Listeners
Learning English For Work
43 Listeners
Miss Me?
244 Listeners
The History Podcast
51 Listeners
The Economics Show
151 Listeners
Rory Stewart: The Long History of...
78 Listeners
The History Bureau
88 Listeners